🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05550077
Recruiting Observational

Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis

NCT05550077 · tracked via the Priya Life Science China tracker
Sponsor
jiaoliqun
Phase
Observational
Started
2020-03-15
Last updated
2022-09-23

Condition(s) studied

Intracranial AtherosclerosisOptical Coherence TomographyPlaque, AtheroscleroticArtery StenosisIschemic Stroke

Investigational drug(s) / intervention(s)

Optical Coherence TomographyPercutaneous transluminal angioplasty and stenting

Optical Coherence Tomography: Intravascular evaluation for vessel wall structure of intracranial atherosclerotic stenosis by application of optical coherence tomography

Percutaneous transluminal angioplasty and stenting: Percutaneous transluminal angioplasty and stenting will be performed follow the standard or adjusted according to OCT evaluation.

Study summary

To evaluate the clinical significance of optical coherence tomography (OCT) in interventional treatment of intracranial atherosclerotic stenosis (ICAS).

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Symptomatic ICAS. Participants with ICAS with a transient ischaemic attack (TIA) or stroke attributable to the territory of the stenotic artery were defined as symptomatic. A TIA was defined as a transient episode of neurological dysfunction (focal weakness or language disturbance, transient monocular blindness, or required assistance in walking) caused by focal brain or retinal ischaemia that lasted for at least 10 minutes but resolved within 24 hours * Stenotic degree ≥ 50%, measured by digital subtraction angiography * The stenosis must located in at least one major intracranial artery (internal carotid artery, vertebral artery, middle cerebral artery, or basilar artery) Exclusion Criteria: * Arteriovenous Malformation * Aneurysm

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xuanwu Hospital, Capital Medical University Beijing Beijing Municipality Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05550077 on ClinicalTrials.gov ↗ ← All trials in China